Development of a Brief form of the Life Skills Profile: The LSP-20

2001 ◽  
Vol 35 (5) ◽  
pp. 677-683 ◽  
Author(s):  
Alan Rosen ◽  
Tom Trauer ◽  
Dusan Hadzi-Pavlovic ◽  
Gordon Parker
Keyword(s):  
Concurrent Validity ◽  
Life Skills ◽  
Short Form ◽  
Reliability And Validity ◽  
Data Sets ◽  
Routine Service ◽  
Individual Care ◽  
Syndrome Scale ◽  
Full Form ◽  
Negative Syndrome

Objective: To develop a brief form of the Life Skills Profile (LSP) that incorporates all five subscales of the full form. Method: A new short form of the LSP (LSP-20) was developed to incorporate all five subscales of the full form. The LSP-20 development was based on a reanalysis of data from previously published studies. These data sets were also reanalysed to determine any differential effects of numbers and percentages of items in the LSP-39, LSP-16 and LSP-20, comparability of scores of the different forms, of test–retest and interrater reliability, and validity of the LSP-20 by comparison with the Positive and Negative Syndrome Scale (PANSS). Results: A twenty-item short form of the LSP-39 (LSP-20) is described whichretains 16 items of an earlier short form but which also reproduces the subscale concerned with disability associated with positive psychotic phenomena. The subscales correlated highly with their counterparts in the full form, interrater and test–retest reliabilities were comparable, and concurrent validity was good. Conclusions: The LSP-20 is a brief form of a widely used instrument that offers equivalent coverage to the full form with sound empirical properties, though unlike the LSP-39, it can be scored in the direction of impairments or strengths. Therefore the LSP-20 may be more suited to routine service disability and aggregated outcome assessments, but less suited than the LSP-39 to detailed research, or to interactive use as part of service user's individual care planning and review.

A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients

2005 ◽  
Vol 72 (2-3) ◽  
pp. 123-129 ◽  
Author(s):  
A. Fresán ◽  
C. De la Fuente-Sandoval ◽  
C. Loyzaga ◽  
M. Garcı́a-Anaya ◽  
N. Meyenberg ◽  
...  
Keyword(s):  
Factor Analysis ◽  
Concurrent Validity ◽  
Syndrome Scale ◽  
Schizophrenic Patients ◽  
Negative Syndrome

Comparison of the Original and Short Form Drinking Motives Questionnaire–Revised With High School and Underage College Student Drinkers

Assessment ◽  
2017 ◽  
Vol 26 (7) ◽  
pp. 1179-1193 ◽  
Author(s):  
Colin R. Harbke ◽  
Jeff Laurent ◽  
Salvatore J. Catanzaro
Keyword(s):  
High School ◽  
College Student ◽  
Concurrent Validity ◽  
Goodness Of Fit ◽  
Short Form ◽  
Reliability And Validity ◽  
Task Demands ◽  
Drinking Motives ◽  
Confirmatory Factor ◽  
Initial Support

Cooper developed and provided initial support for the Drinking Motives Questionnaire–Revised (DMQ-R). More recently, Kuntsche and Kuntsche introduced the briefer DMQ-R SF. Psychometric properties of the DMQ-R and the DMQ-R SF were examined in samples of high school ( n = 131) and underage college student drinkers ( n = 189). The original and short-form versions of the DMQ-R were similar with regard to composite score validity, concurrent validity, and internal consistency. Only the Enhancement Motives subscale showed slight decrements in reliability and validity for the short form. Confirmatory factor analysis showed that the DMQ-R SF was associated with slightly better goodness-of-fit and invariant factor loadings between the high school and college student samples. Despite its briefer form and reduced task demands for participants, the DMQ-R SF appears to provide nearly equivalent, and in some instances slightly improved, measurement of drinking motives in underage drinkers as does the original DMQ-R.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1988 ◽  
Vol 23 (1) ◽  
pp. 99-110 ◽  
Author(s):  
Stanley R. Kay ◽  
Lewis A. Opler ◽  
Jean-Pierre Lindenmayer
Keyword(s):  
Reliability And Validity ◽  
Syndrome Scale ◽  
Negative Syndrome

scholarly journals Clinical relevance of findings in trials of antipsychotics: systematic review

2011 ◽  
Vol 198 (5) ◽  
pp. 341-345 ◽  
Author(s):  
Peter Lepping ◽  
Rajvinder S. Sambhi ◽  
Richard Whittington ◽  
Steven Lane ◽  
Rob Poole
Keyword(s):  
Systematic Review ◽  
Clinical Relevance ◽  
Rating Scale ◽  
Data Sets ◽  
Syndrome Scale ◽  
Minimal Improvement ◽  
Psychiatric Rating ◽  
Psychiatric Rating Scale ◽  
First And Second Generation ◽  
Negative Syndrome

BackgroundThere is concern over the methods used to evaluate antipsychotic drugs.AimsTo assess the clinical relevance of findings in the literature.MethodA systematic review identified studies of antipsychotics that used the Brief Psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS). A published method of translating these into Clinical Global Impression – Change scale (CGI–C) scores was used to measure clinical relevance.ResultsIn total 98 data-sets were included in the BPRS analysis and 202 data-sets in the PANSS analysis. When aggregated scores were translated into notional CGI–C scores, most drugs reached ‘minimal improvement’ on the BPRS, but few reached that level for PANSS. This was true of both first- and second-generation drugs, including clozapine. Amisulpride and olanzapine had better than average CGI–C scores.ConclusionsOur findings show improvements of limited clinical relevance. The CGI–C scores were better for the BPRS than for the PANSS.

Symptoms and social functioning features in chronic schizophrenia are aggregate in a tripartite structure

2001 ◽  
Vol 10 (3) ◽  
pp. 186-193 ◽  
Author(s):  
Vittorio Di Michele ◽  
Francesca Bolino ◽  
Gabriella Di Zio ◽  
Paola Pincini
Keyword(s):  
Cluster Analysis ◽  
Social Functioning ◽  
Clinical Global Impression ◽  
Life Skills ◽  
Chronic Schizophrenia ◽  
Sulla Base ◽  
Sono Stati ◽  
Syndrome Scale ◽  
Negative Syndrome

RIASSUNTOScopo – Verificare l'esistenza di correlazioni fra sintomatologia schizofrenica e variabili multidimensionali del funzionamento sociale e se tali correlazioni possano condurre ad una precisazione classificativa orientata sull'esito attraverso una metodica empirica. Disegno – Quaranta pazienti affetti da schizofrenia cronica con diagnosi accertata clinicamente e attraverso criteri diagnostici sono stati arruolati. Setting – I pazienti erano in carico ad un Centro di Salute Mentale ed erano in fase stabilizzata di malattia definita con criteri operativi. Principali misure utilizzate – Per la valutazione psicopatologica è stata utilizzata la Positive And Negative Syndrome Scale e la Clinical Global Impression. Il funzionamento sociale è stato valutato con la Life Skills Profile e la Scala di Valutazione del Funzionamento Globale. Risultati – Esiste una correlazione fra variabili sintomatologiche e psicosociali che suggerisce un costrutto unitario. A tali variabili soggiaciono 2 fattori principali in grado di spiegare il 79% della varianza che consentono di differenziare il campione in tre gruppi sulla base della Cluster analysis. Sia i sintomi positivi che negativi risultano embricati con alcune aspetti del funzionamento sociale, ma non con tutti. Conclusioni – I sintomi e le variabili psicosociali dei pazienti si aggregano in una struttura omogenea tripartitica. Tale dato suggerisce l'esistenza, nell'ambito di un concetto unitario, di una differenziazione sindromica derivabile con criteri empirici e orientata prognosticamente.

scholarly journals СТРАТЕГІЯ ТА ПРИНЦИПИ ТЕРАПІЇ ПАЦІЄНТІВ ІЗ ШИЗОФРЕНІЄЮ І КОМОРБІДНИМИ СЕРЦЕВО-СУДИННИМИ ЗАХВОРЮВАННЯМИ

2019 ◽  
pp. 141-144
Author(s):  
Ye. V. Opryа
Keyword(s):  
Mental Disorder ◽  
Short Form ◽  
Social Performance ◽  
Syndrome Scale ◽  
Sf 36 ◽  
Negative Syndrome ◽  
Performance Scale

Коморбідність психічних розладів із соматичною патологією являє собою одну з провідних та надскладних проблем сучасної психіатричної практики, зокрема в питаннях терапії. Шизофренія є одним із найрозповсюдженіших психічних розладів, що характеризується високою частотою поєднання з соматичною патологією, наявність якої відмічають майже у кожного другого хворого на шизофренію. Мета дослідження – на основі комплексного аналізу клініко-психопатологічних особливостей шизофренії, що поєднана із серцево-судинними захворюваннями, розробити стратегію та принципи її терапії. Матеріали і методи. В якості методів дослідження використовували: клініко-психопатологічний метод, який доповнювали застосуванням клінічної рейтингової шкали позитивної та негативної симптоматик (Positive and Negative Syndrome Scale – PANSS) для оцінки психопатологічних проявів; а також психодіагностичний метод із застосуванням модифікованого варіанта методики Дембо–Рубінштейна для визначення особливостей самооцінки загального стану здоров’я та окремо психічного й фізичного здоров’я; адаптованого варіанта методики SUMD (The Scale to Assess Unawareness of Mental Disorder) для оцінки рівня “інсайту” психічної хвороби; та короткого опитувальника сприйняття хвороби (КОCХ, BIPQ) в адаптації В. М. Ялтонського; шкали особистісного та соціального функціонування (Personal and Social Performance Scale (PSP)) та короткої форми опитувальника про стан здоров’я (The 36-Item Short Form Survey (SF-36) для оцінки якості життя обстежених хворих. Результати досліджень та їх обговорення. У дослідженні обстежено 100 хворих на шизофренію (F20), з яких 50 осіб із наявністю хронічної серцево-судинної патології склали основну групу дослідження, 50 пацієнтів без хронічного соматичного обтяження контрольну. До основної групи залучали пацієнтів із шизофренією і серцево-судинними захворюваннями (ССЗ) тривалістю не менше 3-х років, які на момент дослідження були компенсовані. Пацієнти з постінсультними та постінфарктними станами в дослідження не брали. В структурі серцево-судинної патології хворих основної групи переважали: ішемічна хвороба серця – 64 % та гіпертонічна хвороба – 52 %, також були представлені порушення серцевого ритму – 14 %, кардіоміопатії – 6 %, вади серця (4 %) та варикозне розширення судин (4 %). У більшості випадків спостерігали коморбідність декількох серцево-судинних захворювань одночасно. Висновки. Виділено та описано провідні стратегічні завдання та тактику терапії хворих, що включали: купірування антипсихотичної симптоматики з урахуванням специфіки соматичного стану; опанування навичок контролю соматичного симптому та стресу, а також підвищення соціальної компетентності та соціально-особистісного функціонування пацієнтів. Урахування соматичного стану осіб із коморбідними серцево-судинними захворюваннями дозволяє підвищити рівень їх соціальної компетентності.

scholarly journals Validation of an 8-item Recovery Assessment Scale (RAS-8) for people with schizophrenia in China

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Si-jia He ◽  
Yan-wen Fang ◽  
Zi-xin Huang ◽  
Yu Yu
Keyword(s):  
Quality Of Life ◽  
Factor Structure ◽  
Concurrent Validity ◽  
Short Form ◽  
Reliability And Validity ◽  
Weighted Kappa ◽  
Patient Functioning ◽  
Recovery Assessment ◽  
Test Retest Reliability

Abstract Background The 24-item Recovery Assessment Scale (RAS) is the most widely-used and well-validated tool for measuring recovery for people with mental illness. The current study aims to assess the reliability and validity of an 8-item short form of RAS (RAS-8) among a Chinese sample of people living with schizophrenia. Methods A sample of 400 people living with schizophrenia were recruited for scale validation. Internal consistency was tested by calculating Cronbach's α. Test–retest reliability was calculated using the intraclass correlation coefficient (ICC) for the total score and weighted kappa for each item. Factor structure was tested with confirmatory factor analysis, and concurrent validity was examined by investigating the correlation of the RAS-8 with patient symptoms, disability, depression, anxiety, patient functioning, quality of life and general health. Results The RAS-8 full scale and subscales showed good internal consistency with Cronbach’s alpha ranging from 0.87 to 0.92. ICC of 0.99 and weighted kappa ranged from 0.62 to 0.88, which generally indicates good test–retest reliability. The findings supported an a priori two-factor structure, χ2/df = 2.93, CFI = 0.98, TLI = 0.98, RMSEA = 0.07, SRMR = 0.035. Concurrent validity of the RAS-8 was further supported by its significant negative correlations with patient symptoms (r =  −0.24, p < 0.01), disability (r =  −0.30, p < 0.01), depression (r =  −0.16, p < 0.05), and anxiety (r =  −0.14, p < 0.05), and its significant positive relationships with patient functioning (r = 0.26, p < 0.01), quality of life (r = 0.39, p < 0.01) and general health (r = 0.34, p < 0.01). Conclusions This study confirmed the reliability and validity of an 8-item short-form RAS for people living with schizophrenia in Chinese communities. The validation of the RAS-8 allows for its use as an alternative for the full RAS as a rapid assessment tool in clinical and research settings. The findings are discussed for their implications for application and validation with other populations and in other countries.

Factor Structure of the Positive and Negative Syndrome Scale (PANSS) Differs by Sex

2018 ◽  
Vol 11 (4) ◽  
pp. 207-213 ◽  
Author(s):  
Julie Walsh-Messinger ◽  
Daniel Antonius ◽  
Mark Opler ◽  
Nicole Aujero ◽  
Deborah M. Goetz ◽  
...  
Keyword(s):  
Factor Structure ◽  
Syndrome Scale ◽  
Negative Syndrome

Risk factors associated with treatment-resistant schizophrenia in first-episode psychosis

2017 ◽  
Vol Ano 7 ◽  
pp. 8-12
Author(s):  
Ana Beatriz de Oliveira Assis ◽  
Jayse Gimenez Pereira Brandão ◽  
Pedro Otávio Piva Espósito ◽  
Osmar Tessari Junior ◽  
Bruno Berlucci Ortiz
Keyword(s):  
Risk Factors ◽  
First Episode Psychosis ◽  
First Episode ◽  
Treatment Resistant ◽  
Factors Associated ◽  
Syndrome Scale ◽  
Episode Psychosis ◽  
Negative Syndrome

Objetivo: Ainda não está claro quais são os fatores de risco para a esquizofrenia resistente ao tratamento (ERT) em primeiro episódio psicótico (PEP). O objetivo deste trabalho é investigar indicadores de risco para ERT em PEP. Métodos: Foram selecionados 53 pacientes em primeiro episódio psicótico, com diagnóstico de esquizofrenia, que deram entrada à enfermaria de psiquiatria do Hospital das Clínicas Luzia de Pinho Melo entre 2011 e 2015. Ao ser admitido na enfermaria, o paciente era avaliado com a Escala de Sintomas para as Síndromes Positiva e Negativa (Positive and Negative Syndrome Scale – PANSS) e recebia tratamento inicial por 4 semanas. Caso sua resposta fosse inferior a 40% de redução na PANSS, o antipsicótico era trocado, e as escalas eram aplicadas novamente após mais 4 semanas. Após a falha com dois antipsicóticos, em doses plenas, por 4 semanas cada, a clozapina era introduzida, e o paciente era considerado ERT. Uma regressão logística foi aplicada onde sexo, idade de início, tempo de doença não tratada, uso de substâncias, avaliação global do funcionamento inicial e PANSS inicial total foram inseridos como variáveis independentes, e ERT foi inserida como variável dependente. Resultados: Tempo de doença não tratada apresentou significância de p = 0,038 e Exp (B) = 4,29, enquanto que PANSS total apresentou p = 0,012 e Exp (B) = 1,06. Conclusão: Identificar os fatores associados à resistência precoce ao tratamento poderia permitir aos clínicos evitar o atraso na introdução da clozapina e prevenir um pior prognóstico para esses pacientes.

Sign in / Sign up

Export Citation Format

Share Document